Literature DB >> 18493021

Computational study of the putative active form of protein Z (PZa): sequence design and structural modeling.

Vasu Chandrasekaran1, Chang Jun Lee, Robert E Duke, Lalith Perera, Lee G Pedersen.   

Abstract

Although protein Z (PZ) has a domain arrangement similar to the essential coagulation proteins FVII, FIX, FX, and protein C, its serine protease (SP)-like domain is incomplete and does not exhibit proteolytic activity. We have generated a trial sequence of putative activated protein Z (PZa) by identifying amino acid mutations in the SP-like domain that might reasonably resurrect the serine protease catalytic activity of PZ. The structure of the activated form was then modeled based on the proposed sequence using homology modeling and solvent-equilibrated molecular dynamics simulations. In silico docking of inhibitors of FVIIa and FXa to the putative active site of equilibrated PZa, along with structural comparison with its homologous proteins, suggest that the designed PZa can possibly act as a serine protease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18493021      PMCID: PMC2492813          DOI: 10.1110/ps.034801.108

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  33 in total

1.  Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding.

Authors:  K P Hopfner; A Lang; A Karcher; K Sichler; E Kopetzki; H Brandstetter; R Huber; W Bode; R A Engh
Journal:  Structure       Date:  1999-08-15       Impact factor: 5.006

2.  Structure of human factor VIIa and its implications for the triggering of blood coagulation.

Authors:  A C Pike; A M Brzozowski; S M Roberts; O H Olsen; E Persson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

3.  Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensity.

Authors:  Katrin Groebke Zbinden; David W Banner; Kurt Hilpert; Jacques Himber; Thierry Lavé; Markus A Riederer; Martin Stahl; Thomas B Tschopp; Ulrike Obst-Sander
Journal:  Bioorg Med Chem       Date:  2006-04-18       Impact factor: 3.641

4.  A proposed structural model of human protein Z.

Authors:  C J Lee; V Chandrasekaran; R E Duke; L Perera; L G Pedersen
Journal:  J Thromb Haemost       Date:  2007-04-20       Impact factor: 5.824

5.  Enzyme specificity under dynamic control: a normal mode analysis of alpha-lytic protease.

Authors:  D W Miller; D A Agard
Journal:  J Mol Biol       Date:  1999-02-12       Impact factor: 5.469

6.  Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).

Authors:  G Kemball-Cook; D J Johnson; E G Tuddenham; K Harlos
Journal:  J Struct Biol       Date:  1999-10       Impact factor: 2.867

7.  Molecular markers of serine protease evolution.

Authors:  M M Krem; E Di Cera
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

8.  Protein Z and protein Z-dependent protease inhibitor. Determinants of levels and risk of venous thrombosis.

Authors:  Ali Al-Shanqeeti; Astrid van Hylckama Vlieg; Erik Berntorp; Frits R Rosendaal; George J Broze
Journal:  Thromb Haemost       Date:  2005-03       Impact factor: 5.249

9.  Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor.

Authors:  A Tabatabai; R Fiehler; G J Broze
Journal:  Thromb Haemost       Date:  2001-04       Impact factor: 5.249

10.  Genomic evidence for a simpler clotting scheme in jawless vertebrates.

Authors:  Russell F Doolittle; Yong Jiang; Justin Nand
Journal:  J Mol Evol       Date:  2008-02-19       Impact factor: 3.973

View more
  3 in total

1.  Participation of protein Z-dependent protease inhibitor and protein Z system in the pathomechanism of thrombotic complications.

Authors:  Małgorzata A Gacka; Rafał Małecki; Rajmund Adamiec
Journal:  Int J Angiol       Date:  2010

2.  Basis for the specificity and activation of the serpin protein Z-dependent proteinase inhibitor (ZPI) as an inhibitor of membrane-associated factor Xa.

Authors:  Xin Huang; Alexey Dementiev; Steven T Olson; Peter G W Gettins
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

Review 3.  Vitamin K - sources, physiological role, kinetics, deficiency, detection, therapeutic use, and toxicity.

Authors:  Přemysl Mladěnka; Kateřina Macáková; Lenka Kujovská Krčmová; Lenka Javorská; Kristýna Mrštná; Alejandro Carazo; Michele Protti; Fernando Remião; Lucie Nováková
Journal:  Nutr Rev       Date:  2022-03-10       Impact factor: 7.110

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.